Etzer Darout
Stock Analyst at Barclays
(4.89)
# 282
Out of 4,423 analysts
483
Total ratings
55.6%
Success rate
25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Etzer Darout
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRRK Scholar Rock Holding | Maintained: Buy | $55 | $47.33 | +16.21% | 19 | Jun 18, 2026 | |
| CCCC C4 Therapeutics | Maintained: Buy | $7 | $4.15 | +68.67% | 28 | Jun 18, 2026 | |
| XNCR Xencor | Maintained: Buy | $27 | $12.64 | +113.61% | 30 | Jun 16, 2026 | |
| ABVX ABIVAX Société Anonyme | Maintained: Buy | $148 | $99.15 | +49.27% | 10 | Jun 16, 2026 | |
| INCY Incyte | Maintained: Buy | $117 | $98.22 | +19.12% | 13 | Jun 15, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | $409 | $270.15 | +51.40% | 7 | Jun 15, 2026 | |
| LEGN Legend Biotech | Maintained: Buy | $80 | $27.93 | +186.43% | 9 | Jun 15, 2026 | |
| NUVL Nuvalent | Downgraded: Hold | $152 → $124 | $123.43 | +0.46% | 24 | Jun 9, 2026 | |
| KURA Kura Oncology | Maintained: Buy | $28 | $9.93 | +181.97% | 11 | Jun 4, 2026 | |
| ARVN Arvinas | Maintained: Buy | $20 | $7.67 | +160.76% | 35 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $3.91 | +181.33% | 10 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 | $13.75 | +30.91% | 9 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $9.16 | +227.51% | 10 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $234 → $253 | $224.66 | +12.61% | 5 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $27 | $15.88 | +70.03% | 6 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $11.91 | +135.10% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $67.47 | +85.27% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $17.42 | +129.62% | 2 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $160 | $72.34 | +121.18% | 7 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $4.13 | +45.28% | 33 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 → $75 | $57.51 | +30.41% | 9 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $48 | $32.43 | +48.01% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $3 | $2.63 | +14.07% | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $2.95 | +442.37% | 30 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $14 | $14.22 | -1.55% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 | $51.91 | -13.31% | 32 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $119 | $112.86 | +5.44% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $37 | $19.00 | +94.74% | 12 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $119 | $90.43 | +31.59% | 5 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $3.57 | n/a | 1 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 → $143 | $90.89 | n/a | 10 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $147.08 | n/a | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.09 | n/a | 16 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.90 | n/a | 4 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $25.27 | n/a | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $17.55 | n/a | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.15 | n/a | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.57 | n/a | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $63 | $0.453 | n/a | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 2,445 → kr 2,612 | $1,653.67 | n/a | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $37 | $107.13 | n/a | 2 | Sep 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $0.8503 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.000001 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $25 | $5.85 | n/a | 2 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $3.98 | n/a | 2 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €22.69 → €26.18 | $3.06 | n/a | 2 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $162 | $278.09 | n/a | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $23.14 | n/a | 4 | Jul 14, 2020 |
Scholar Rock Holding
Jun 18, 2026
Maintained: Buy
Price Target: $55
Current: $47.33
Upside: +16.21%
C4 Therapeutics
Jun 18, 2026
Maintained: Buy
Price Target: $7
Current: $4.15
Upside: +68.67%
Xencor
Jun 16, 2026
Maintained: Buy
Price Target: $27
Current: $12.64
Upside: +113.61%
ABIVAX Société Anonyme
Jun 16, 2026
Maintained: Buy
Price Target: $148
Current: $99.15
Upside: +49.27%
Incyte
Jun 15, 2026
Maintained: Buy
Price Target: $117
Current: $98.22
Upside: +19.12%
BeOne Medicines AG
Jun 15, 2026
Maintained: Buy
Price Target: $409
Current: $270.15
Upside: +51.40%
Legend Biotech
Jun 15, 2026
Maintained: Buy
Price Target: $80
Current: $27.93
Upside: +186.43%
Nuvalent
Jun 9, 2026
Downgraded: Hold
Price Target: $152 → $124
Current: $123.43
Upside: +0.46%
Kura Oncology
Jun 4, 2026
Maintained: Buy
Price Target: $28
Current: $9.93
Upside: +181.97%
Arvinas
Jun 3, 2026
Maintained: Buy
Price Target: $20
Current: $7.67
Upside: +160.76%
Jun 2, 2026
Maintained: Buy
Price Target: $11
Current: $3.91
Upside: +181.33%
Jun 2, 2026
Maintained: Hold
Price Target: $18
Current: $13.75
Upside: +30.91%
Jun 1, 2026
Maintained: Buy
Price Target: $30
Current: $9.16
Upside: +227.51%
May 27, 2026
Reiterated: Buy
Price Target: $234 → $253
Current: $224.66
Upside: +12.61%
May 20, 2026
Maintained: Buy
Price Target: $21 → $27
Current: $15.88
Upside: +70.03%
May 15, 2026
Maintained: Buy
Price Target: $28
Current: $11.91
Upside: +135.10%
May 15, 2026
Maintained: Buy
Price Target: $125
Current: $67.47
Upside: +85.27%
May 15, 2026
Maintained: Buy
Price Target: $40
Current: $17.42
Upside: +129.62%
May 13, 2026
Rated: Buy
Price Target: $160
Current: $72.34
Upside: +121.18%
May 13, 2026
Rated: Buy
Price Target: $6
Current: $4.13
Upside: +45.28%
May 13, 2026
Rated: Buy
Price Target: $63 → $75
Current: $57.51
Upside: +30.41%
May 8, 2026
Rated: Buy
Price Target: $45 → $48
Current: $32.43
Upside: +48.01%
May 8, 2026
Rated: Sell
Price Target: $3
Current: $2.63
Upside: +14.07%
May 8, 2026
Rated: Buy
Price Target: $16
Current: $2.95
Upside: +442.37%
May 8, 2026
Rated: Sell
Price Target: $14
Current: $14.22
Upside: -1.55%
May 6, 2026
Maintained: Hold
Price Target: $45
Current: $51.91
Upside: -13.31%
May 6, 2026
Maintained: Buy
Price Target: $119
Current: $112.86
Upside: +5.44%
May 1, 2026
Maintained: Buy
Price Target: $35 → $37
Current: $19.00
Upside: +94.74%
Dec 8, 2025
Maintained: Buy
Price Target: $70 → $119
Current: $90.43
Upside: +31.59%
Apr 4, 2025
Maintained: Buy
Price Target: $9
Current: $3.57
Upside: n/a
Mar 11, 2025
Maintained: Buy
Price Target: $130 → $143
Current: $90.89
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $147.08
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $2.09
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $11.90
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $25.27
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $17.55
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $4.15
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $1.57
Upside: n/a
Feb 27, 2025
Initiated Coverage: Buy
Price Target: $63
Current: $0.453
Upside: n/a
Aug 11, 2022
Maintained: Hold
Price Target: kr 2,445 → kr 2,612
Current: $1,653.67
Upside: n/a
Sep 13, 2021
Maintained: Buy
Price Target: $38 → $37
Current: $107.13
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $60
Current: $0.8503
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Mar 17, 2021
Maintained: Buy
Price Target: $16 → $25
Current: $5.85
Upside: n/a
Mar 11, 2021
Reiterated: Buy
Price Target: $50 → $48
Current: $3.98
Upside: n/a
Mar 5, 2021
Maintained: Buy
Price Target: €22.69 → €26.18
Current: $3.06
Upside: n/a
Feb 22, 2021
Downgraded: Hold
Price Target: $162
Current: $278.09
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: $48
Current: $23.14
Upside: n/a